These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 29029905)
1. Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study. Antia C; Hone N; Gloster H J Am Acad Dermatol; 2017 Nov; 77(5):967-968. PubMed ID: 29029905 [No Abstract] [Full Text] [Related]
2. New Oral Anticoagulants: What Prescribers Should Know; Differences and Similarities between Warfarin and "New Agents" (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - Review of Indications, Contraindications and Safety of Use. Petrasko M; Raizada A; Petraskova T S D Med; 2016 Aug; 69(8):363-369. PubMed ID: 28806005 [No Abstract] [Full Text] [Related]
4. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243 [No Abstract] [Full Text] [Related]
5. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants. Sivolella S; De Biagi M; Brunello G; Berengo M; Pengo V Odontology; 2015 Sep; 103(3):258-63. PubMed ID: 25656043 [TBL] [Abstract][Full Text] [Related]
6. Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions. Pan EY; Sobieraj DM Conn Med; 2016 Feb; 80(2):105-11. PubMed ID: 27024982 [No Abstract] [Full Text] [Related]
7. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548 [TBL] [Abstract][Full Text] [Related]
8. The Total Incidence of Complications and the Impact of an Anticoagulation Regime on Adverse Events After Cryoballoon Ablation of Atrial Fibrillation: A Single-Center Study of 409 Patients. Koektuerk B; Turan CH; Yorgun H; Keskin K; Schoett M; Dahmen A; Gorr E; Yang A; Hoppe C; Horlitz M; Turan RG Cardiovasc Ther; 2016 Jun; 34(3):144-51. PubMed ID: 26880220 [TBL] [Abstract][Full Text] [Related]
9. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know. Steed MB; Swanson MT Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of bleeding complications due to oral anticoagulant drugs]. Riess H Laryngorhinootologie; 2015 Oct; 94(10):697-709. PubMed ID: 26468622 [No Abstract] [Full Text] [Related]
11. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery. Siscos SM; Neill BC; Singh AH; Hocker TLH J Am Acad Dermatol; 2021 Feb; 84(2):425-431. PubMed ID: 33045293 [TBL] [Abstract][Full Text] [Related]
12. Outcome of Secondary Stroke Prevention in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants. Nakase T; Moroi J; Ishikawa T J Stroke Cerebrovasc Dis; 2018 May; 27(5):1174-1177. PubMed ID: 29276013 [TBL] [Abstract][Full Text] [Related]
15. Trends and Characteristics of Emergency Department Patients Prescribed Novel Oral Anticoagulants. Ganetsky M J Emerg Med; 2015 Nov; 49(5):693-7. PubMed ID: 26149803 [TBL] [Abstract][Full Text] [Related]
16. Practical recommendations on incorporating new oral anticoagulants into routine practice. Randhawa J; Thiruchelvam N; Ghobrial M; Spiro T; Clark B; Haddad A; Daw H Clin Adv Hematol Oncol; 2014 Oct; 12(10):675-83. PubMed ID: 25658892 [TBL] [Abstract][Full Text] [Related]
17. Differences between activities of coagulation factors after one month of therapy with different direct oral anticoagulant in pulmonary embolism patients. Dzudovic J; Dzudovic B; Subota V; Antunovic M; Stavric M; Subotic B; Obradovic S J Clin Pharm Ther; 2019 Apr; 44(2):236-242. PubMed ID: 30411377 [TBL] [Abstract][Full Text] [Related]
18. Body weight is negatively associated with direct oral anticoagulant trough concentrations in dabigatran and apixaban users. Borst JM; van Rein N; Bakker ECMD; Vukadin N; Rier M; Mairuhu ATA; Hudig F; Bosma LBE; Wilms EB; Visser LE Br J Haematol; 2020 Dec; 191(5):941-944. PubMed ID: 32738053 [No Abstract] [Full Text] [Related]
19. [Monitoring options and reversal agents for oral anticoagulants]. Thorup SB; Husted SE; Vang ML Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568 [TBL] [Abstract][Full Text] [Related]
20. [Is one DOAC better than another?]. Pos L Ned Tijdschr Geneeskd; 2021 Apr; 164():. PubMed ID: 33914427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]